drug
Japan's Daiichi Sankyo gets US FDA nod for blood cancer treatment
Posted in Medicine on 21st Jul, 2023
by Alex Muller
AML is one of the most common types of blood cancer in adults. Mutations in the FLT3 gene, which plays a role in helping white blood cells grow, can cause excess growth of these cells and lead to an aggressive form of leukemia.
FDA grants fast track designation to myelofibrosis, nasopharyngeal cancer therapies
Posted in Medicine on 21st Jul, 2023
by Alex Muller
The FDA granted fast track designation to two oncology therapies.
Tislelizumab Plus Bevacizumab/Chemo Demonstrates Early Efficacy in Cervical Cancer
Posted in Medicine on 20th Jul, 2023
by Alex Muller
The addition of the PD-L1 inhibitor tislelizumab to standard bevacizumab and platinum-doublet chemotherapy in the first-line setting prolonged progression-free survival, produced encouraging responses, and was well tolerated in patients with cervical cancer.
New Alzheimer's drugs offer hope for bleak diagnosis but remain out of reach in UK
Posted in Medicine on 20th Jul, 2023
by Alex Muller
Estimates by Alzheimer's Research UK and Alzheimer's Society suggest 720,000 people in the UK would meet the treatment criteria used in the clinical trials of lecanemab and donanemab. But they need a diagnosis the NHS just can't deliver.
Most blood pressure meds found to reduce frequency of migraine headaches
Posted in Medicine on 27th Jun, 2023
by Alex Muller
A new study by researchers at The George Institute for Global Health in Sydney, Australia, has found that almost all classes of antihypertensives have some ability to reduce the frequency of headaches in migraine sufferers.